Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
Cancer research and treatment - 1 Apr 2019
Park Song Ee, Noh Jae Myoung, Kim You Jin, Lee Han Sang, Cho Jang Ho, Lim Sung Won, Ahn Yong Chan, Pyo Hongryull, Choi Yoon-La, Han Joungho, Sun Jong-Mu, Lee Se Hoon, Ahn Jin Seok, Park Keunchil, Ahn Myung-Ju
Abstract excerpt
PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2008 to December 2013, the medical records of 197 patients with stage III non- squamous non-small cell lung cancer...
Topics
- Adult
- Aged
- Biomarkers, Tumor
- Chemoradiotherapy
- ErbB Receptors
- Female
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms
- Male